전동재 (Dallas Baptist University) | 한빛사논문 > 한빛사

한빛사논문

조회249

Dallas Baptist University

Proc. Natl. Acad. Sci. USA, May 20 2025, 122 (20) | https://doi.org/10.1073/pnas.2426532122 Allosteric regulation of UBIAD1 trafficking from ER to Golgi revealed by chemical genetic screening

Dong-Jae Jun ¹, Marc M Schumacher ¹, Youngah Jo ¹, Rebecca A Faulkner ¹, Yangyang Yang ², Jet Tsien ², Tian Qin ², Russell A DeBose-Boyd ^{1 *}

¹Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
²Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.

^*Corresponding author: correspondence to Russell A DeBose-Boyd

Abstract

Schnyder corneal dystrophy (SCD) is a rare autosomal dominant condition characterized by the opacification of the cornea owing to the abnormal deposition of cholesterol. SCD-associated mutations have been identified in the gene encoding UbiA prenyltransferase domain-containing protein-1 (UBIAD1), which uses geranylgeranyl pyrophosphate (GGpp) to synthesize the vitamin K₂ subtype menaquinone-4 (MK-4). Beyond its enzymatic role, UBIAD1 serves as a key regulator of the endoplasmic reticulum (ER)-localized enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), the rate-limiting enzyme in the mevalonate pathway that produces cholesterol and nonsterol isoprenoids such as GGpp and MK-4. Sterol-induced binding to UBIAD1 inhibits the sterol-accelerated ER-associated degradation (ERAD) of HMGCR to maintain the synthesis of nonsterol isoprenoids under conditions of cholesterol repletion. GGpp dissociates the HMGCR-UBIAD1 complex, triggering maximal ERAD of HMGCR and ER-to-Golgi translocation of UBIAD1. However, SCD-associated UBIAD1 resists this GGpp-induced dissociation and remains sequestered in the ER. ER retention of UBIAD1 leads to inhibition of HMGCR ERAD, promoting increased synthesis and accumulation of cholesterol. Here, chemical genetic screening was utilized to identify molecules that restored Golgi localization of SCD-associated UBIAD1 (N102S) and thereby relieve inhibition of HMGCR ERAD. We found that the chemotherapeutic tyrosine kinase inhibitor Apatinib stimulated ER-to-Golgi transport of both N102S and wild type UBIAD1. This effect required GGpp but was independent of Apatinib's tyrosine kinase inhibition. Apatinib-mediated Golgi transport of UBIAD1 enhanced the ERAD of HMGCR. Photoaffinity labeling studies indicated that Apatinib binds directly to UBIAD1, suggesting that the drug allosterically activates GGpp-induced transport of UBIAD1 from the ER to the Golgi.

논문정보

형식Research article
게재일2025년 05월 (BRIC 등록일 2025-05-22)
연구진국외 연구진
분야 의약학 > 분자세포의학

댓글 작성 로그인

CV 열람하기

연락처 보기